Ethyl 4-chloro-[1,2,4]triazolo[4,3-a]quinoxaline-1-carboxylate, 95%, 100mg

tert-Butyl ((5-(aminomethyl)pyridin-2-yl)methyl)carbamate, 95%, 50mg

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)aniline, 98%, 1g

4-Chloro-3-(trifluoromethyl)pyridine, 98.0%, 1g

4-(4-ETHYNYLPHENYL)MORPHOLINE, 95.0%, 5g

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 2 - MWCO 12,000 to 14,000, 10 mm, 1 Piece(s)

5-Amino-2-fluoro-3-picoline, 95.0%, 1g

2-Isopropoxy-4-methoxybenzonitrile, 97%, 1g

N,N-Dichloroformylmethylamine, 250mg

4-(4-(3-(Pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide, 95%, 10mg

(2R,4S)-1-(tert-Butoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid, 95.0%, 10g

2-Bromo-3-fluoro-5-methylaniline, 97.0%, 1g

Ethanone, 1-[1-[2-(methylsulfonyl)phenyl]-7-propoxy-3-indolizinyl]-, 50mg